The Times Australia
News From Asia

.

Appier Appoints Dr. Che-hsu Chang as Chief Strategy Officer

Former Senior Leader of McKinsey and Co. and IQVIA brings business acumen to drive Appier’s next phase of growth and innovation

TAIPEI, TAIWAN - Media OutReach - 7 April 2022 - Appier, a leading artificial intelligence (AI) software-as-a-service (SaaS) company, announces today the appointment of Dr.

Che-hsu "Joe" Chang as its Chief Strategy Officer. Dr. Chang, a business veteran with more than 12 years of experience across business strategy, product management and management consulting, will help drive the company's growth, strengthen its strategic deployment in the AI market, and accelerate its strong momentum in new market expansion and vigorous market-driven product innovation.

Appier Appoints Dr. Che-hsu Chang as Chief Strategy Officer

In this capacity, Dr. Chang will lead Appier's mergers and acquisitions (M&A), partnership and corporate strategy, as well as oversee Appier's overall business health and growth opportunities globally. He is based in New York and New Jersey, US, and will be partnering with Appier's senior leaders across business units and regions, strategizing for global opportunities that can propel Appier's growth, especially in new markets.

"I am delighted to welcome Dr. Joe Chang to Appier. Joe's multifaceted experience in corporate strategy makes him the best fit to lead Appier's growth strategy and accelerate our success," said Dr. Chih-han Yu, CEO and Co-founder of Appier. "With Joe on our team, I believe we will be able to explore more business possibilities to help us stay competitive and enhance our overall capacity for rapid growth in 2022 and beyond."

"Appier is a rapidly growing AI SaaS company with a strong focus on customer-centric marketing solutions. I'm thrilled to be part of Appier and look forward to working with world-class talents to drive business and organizational growth as well as efficiency," said Dr. Chang. "I am eager to bring my experiences in industries, businesses and technologies to the new role to build upon Appier's success and sustain long-term growth."

Dr. Chang was most recently the Senior Principal of Real World Technology Solutions Strategy at IQVIA. During his tenure he led corporate strategy, co-led M&A and partnership initiatives, as well as drove innovation in product development and commercialization of artificial intelligence/machine learning-based products and services.

Dr. Chang began his career at McKinsey and Co. in the US, where he co-led and grew the company's healthcare and business technology practices as an Associate Partner. He also led research operations and product development at Flatiron Health, a startup acquired by Roche in 2018. Dr. Chang's expertise is focused on the intersections between business strategy, technology and analytics.

Dr. Chang holds a Doctor of Science degree in Public Health from Harvard University and a Master of Science and Bachelor of Science degrees from National Taiwan University.

For more information, please visit www.appier.com/news.

About Appier

Appier (TSE: 4180) is a software-as-a-service (SaaS) company that uses artificial intelligence (AI) to power business decision-making. Founded in 2012 with a vision of democratizing AI, Appier now has 17 offices across APAC, Europe and U.S., and is listed on the Tokyo Stock Exchange. Visit for more company information and visit for more IR information.

#Appier

The issuer is solely responsible for the content of this announcement.

Times Magazine

Building a Strong Online Presence with Katoomba Web Design

Katoomba web design is more than just creating a website that looks good—it’s about building an onli...

September Sunset Polo

International Polo Tour To Bridge Historic Sport, Life-Changing Philanthropy, and Breath-Taking Beau...

5 Ways Microsoft Fabric Simplifies Your Data Analytics Workflow

In today's data-driven world, businesses are constantly seeking ways to streamline their data anal...

7 Questions to Ask Before You Sign IT Support Companies in Sydney

Choosing an IT partner can feel like buying an insurance policy you hope you never need. The right c...

Choosing the Right Legal Aid Lawyer in Sutherland Shire: Key Considerations

Legal aid services play an essential role in ensuring access to justice for all. For people in t...

Watercolor vs. Oil vs. Digital: Which Medium Fits Your Pet's Personality?

When it comes to immortalizing your pet’s unique personality in art, choosing the right medium is ...

The Times Features

It’s OK to use paracetamol in pregnancy. Here’s what the science says about the link with autism

United States President Donald Trump has urged pregnant women[1] to avoid paracetamol except in ...

How much money do you need to be happy? Here’s what the research says

Over the next decade, Elon Musk could become the world’s first trillionaire[1]. The Tesla board ...

NSW has a new fashion sector strategy – but a sustainable industry needs a federally legislated response

The New South Wales government recently announced the launch of the NSW Fashion Sector Strategy...

From Garden to Gift: Why Roses Make the Perfect Present

Think back to the last time you gave or received flowers. Chances are, roses were part of the bunch...

Do I have insomnia? 5 reasons why you might not

Even a single night of sleep trouble can feel distressing and lonely. You toss and turn, stare...

Wedding Photography Trends You Need to Know (Before You Regret Your Album)

Your wedding album should be a timeless keepsake, not something you cringe at years later. Trends ma...

Can you say no to your doctor using an AI scribe?

Doctors’ offices were once private. But increasingly, artificial intelligence (AI) scribes (al...

There’s a new vaccine for pneumococcal disease in Australia. Here’s what to know

The Australian government announced last week there’s a new vaccine[1] for pneumococcal disease ...

What Makes a Small Group Tour of Italy So Memorable?

Traveling to Italy is on almost every bucket list. From the rolling hills of Tuscany to the sparklin...